The largest database of trusted experimental protocols

D 001206 13 20

Manufactured by Horizon Discovery
Sourced in United States

D-001206-13-20 is a laboratory equipment product. It serves a core function in research and analysis applications. The detailed specifications and intended use of this product are not available for this response.

Automatically generated - may contain errors

4 protocols using d 001206 13 20

1

Epigenetic Regulation in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCCIT and HCT116 parental cells (from ATCC), and the isogenic derivatives of parental HCT116 (Rhee et al., 2002 (link); Sun et al., 2008 (link)) were grown in McCoy's 5A medium supplemented with 10% fetal bovine serum and Lglutamine. HCT116 DNMT overexpression lines (Sun et al., 2008 (link)) were grown under G418 selection (750 μg/ml). Differentiation of NCCIT was induced by addition of 10 μM all-trans retinoic acid (Sigma) for 7 days. On-TARGETplus and siGENOME siRNA SMARTpools (Dharmacon, Thermo Scientific) targeting a single gene were used against DNMT1 (L-004605-00-0005), DNMT3A (M-006672-03-0005), DNMT3B (L-006395-00-0005), and DNMT3L (L-013637-01-0005) in individual and combination experiments. siRNA transfection with a negative control non-targeting siRNA (D-001206-13-20; Dharmacon, Thermo Scientific) was performed in parallel. siRNA transfection was performed with PepMute transfection reagent (SignaGen) according to the manufacturer protocol. Total RNA was extracted by Trizol homogenization and purified according to the manufacturer protocol (Life Technologies). Genomic DNA was extracted by proteinase K digestion and phenol:chloroform extraction. Refer to Supplemental Experimental Procedures for the full siRNA transfection protocol and siRNA rescue experimental conditions.
+ Open protocol
+ Expand
2

Vimentin Knockdown in PC3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used VIM specific Accel smart pool siRNA to knock
down vimentin in PC3 cells, according to the manufacturer’s protocol.
Briefly, PC3 (100,000 cells) were cultured at 37°C and 5% CO2 in 6-well
plate overnight. A stock solution of 100 μM VIM specific
Accel smart pool siRNA (E-0003551-00-0020, Dharmacon, US) in 1x siRNA buffer
(B-002000-UB-100) was prepared. The siRNA was suspended in 300 μL Accel
delivery medium (B-005000-500, Dharmacon, US) to a final concentration of 1
μM and the suspension was shaken for 90 min at room temperature. The
suspension was centrifuged briefly. The culture medium was aspired from each
well and the cells were incubated with 300 μL siRNA suspension in the
Accel delivery medium for 96 h at 37°C and 5% CO2. A control experiment
was carried out in which the cells were incubated with 1 μM non-targeting
siRNA (D-001206-13-20, Dharmacon, US) in the Accel Delivery medium (300
μL) under the same conditions. Finally, the cells were trypsinized and
the vimentin protein level was analysed using the microfluidic approach and flow
cytometry.
+ Open protocol
+ Expand
3

Knockdown of β-catenin gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with 10 nM small interfering RNAs (siRNAs) targeting the CTNNB1 (β-catenin) gene (s437; Ambion), or control siRNAs (D001206-13-20; Dharmacon) using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s protocol. Cells were re-transfected 2 days after the first transfection to increase the effect of RNA interference and harvested 2 days after the second transfection.
+ Open protocol
+ Expand
4

Gene Silencing in 96-Well Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene silencing was performed in a 96F well plate using 5 μL siRNA (500nM stock) mixed with 0.1 μL DharmaFECT1 #1 (Dharmacon) in 4.9 μL IMDM. The mixture was incubated for 20min on a shaker at RT and mixed with 4700 cells/200ul. After three days cells were analyzed using flow cytometry. siGENOME human SPPL3 (D-006042, Dharmacon) and β2m (M-004366, Dharmacon) siRNAs were used to silence SPPL3 and β2m respectively. Non-targeting siRNA (siCTRL, D-001206–13-20, Dharmacon) was used as a negative control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!